Clinical parameters | N | FAM99A expression | χ2 | P | |
---|---|---|---|---|---|
Low expression | High expression | ||||
Agea (years) | Â | Â | Â | 1.548 | 0.213 |
 ≤ 60 | 177 | 94 | 83 |  |  |
 > 60 | 193 | 90 | 103 |  |  |
Gender | Â | Â | Â | 0.006 | 0.941 |
 Male | 250 | 125 | 125 |  |  |
 Female | 121 | 60 | 61 |  |  |
Racea | Â | Â | Â | 1.286 | 0.257 |
 Asian | 158 | 85 | 73 |  |  |
 Non-Asian | 203 | 97 | 106 |  |  |
Hepatitis B virus infectiona | Â | Â | Â | 0.367 | 0.545 |
 Negative | 248 | 120 | 128 |  |  |
 Positive | 104 | 54 | 50 |  |  |
Hepatitis C virus infectiona | Â | Â | Â | 2.743 | 0.098 |
 Negative | 296 | 152 | 144 |  |  |
 Positive | 56 | 22 | 34 |  |  |
Vascular invasiona | Â | Â | Â | 15.688 | < 0.001 |
 None | 206 | 87 | 119 |  |  |
 Microvascular invasion | 93 | 59 | 34 |  |  |
 Macrovascular invasion | 16 | 12 | 4 |  |  |
Histological gradea | Â | Â | Â | 8.413 | 0.004 |
 G1-G2 | 232 | 102 | 130 |  |  |
 G3-G4 | 134 | 80 | 54 |  |  |
Pathological stagea | Â | Â | Â | 1.719 | 0.190 |
 I-II | 257 | 125 | 132 |  |  |
 III-IV | 90 | 51 | 39 |  |  |
T stagea | Â | Â | Â | 1.166 | 0.280 |
 I-II | 275 | 133 | 142 |  |  |
 III-IV | 93 | 51 | 42 |  |  |
N stagea | Â | Â | Â | 0.168 | 0.682 |
 N0 | 252 | 131 | 121 |  |  |
 N1 | 4 | 3 | 1 |  |  |
M stagea | Â | Â | Â | 0.184 | 0.668 |
 M0 | 266 | 137 | 129 |  |  |
 M1 | 4 | 3 | 1 |  |  |
Child-Pugh classification grade a | Â | Â | Â | 3.430 | 0.064 |
 A | 217 | 103 | 114 |  |  |
 B+C | 22 | 15 | 7 |  |  |